Journal article
The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival
Leukemia, Vol.27(2), pp.441-450
02/2013
DOI: 10.1038/leu.2012.185
PMCID: PMC4047128
PMID: 22772059
Abstract
Y-box binding protein 1 (YB-1) functions as a translational regulator and has been suggested to elevate
MYC
mRNA translation via an internal ribosome entry segment (IRES) point mutation in multiple myeloma (MM). We show that YB-1-mediated translation of
MYC
mRNA occurs independently of the reported IRES mutation, as 87 MM patients (
n
= 88) and all tested human MM cell lines (HMCLs) were negative for the mutation. We show for the first time that positive MYC staining predicts YB-1 co-expression in malignant plasma cells and YB-1/MYC co-expression increases from 30% in medullary to 70% in extramedullary MM. YB-1 knockdown in HMCLs reduced both MYC protein levels and
MYC
mRNA in the polysomal fraction, providing a mechanism by which YB-1 controls
MYC
translation. MYC transcription of YB-1 is demonstrated in HMCLs as MYC knockdown resulted in reduced YB-1 protein and mRNA levels. Furthermore, MYC activation in non-malignant mouse embryonic fibroblasts (MEFs) increased
YB-1
mRNA, clearly indicating that MYC drives
YB-1
transcription. Importantly, perturbation of the MYC/YB-1 oncogenic circuit leads to apoptosis in HMCLs. Here, we demonstrate that these two proteins co-regulate each other via combined transcriptional/translational activity establishing their pivotal role in MM cell survival.
We therefore suggest that targeting the YB-1/mRNA interaction provides a new strategy for MM drug development.
Details
- Title: Subtitle
- The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival
- Creators
- K S Bommert - Division of Haematology and Medical Oncology, Department of Internal Medicine II, Comprehensive Cancer Centre Mainfranken, University Hospital Würzburg, Würzburg, GermanyM Effenberger - Division of Haematology and Medical Oncology, Department of Internal Medicine II, Comprehensive Cancer Centre Mainfranken, University Hospital Würzburg, Würzburg, GermanyE Leich - Institute of Pathology, University of Würzburg, Würzburg, GermanyM Küspert - Theodor Boveri Institute, University of Würzburg, Würzburg, GermanyD Murphy - Theodor Boveri Institute, University of Würzburg, Würzburg, GermanyC Langer - Department of Internal Medicine III, University of Ulm, Ulm, GermanyR Moll - Institute of Pathology, University of Giessen and Marburg, Marburg, GermanyS Janz - Department of Pathology, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA, USAA Mottok - Institute of Pathology, University of Würzburg, Würzburg, GermanyS Weissbach - Institute of Pathology, University of Würzburg, Würzburg, GermanyA Rosenwald - Institute of Pathology, University of Würzburg, Würzburg, GermanyR Bargou - Division of Haematology and Medical Oncology, Department of Internal Medicine II, Comprehensive Cancer Centre Mainfranken, University Hospital Würzburg, Würzburg, GermanyK Bommert - Division of Haematology and Medical Oncology, Department of Internal Medicine II, Comprehensive Cancer Centre Mainfranken, University Hospital Würzburg, Würzburg, Germany
- Resource Type
- Journal article
- Publication Details
- Leukemia, Vol.27(2), pp.441-450
- DOI
- 10.1038/leu.2012.185
- PMID
- 22772059
- PMCID
- PMC4047128
- NLM abbreviation
- Leukemia
- ISSN
- 0887-6924
- eISSN
- 1476-5551
- Language
- English
- Date published
- 02/2013
- Academic Unit
- Pathology
- Record Identifier
- 9984083207802771
Metrics
10 Record Views